MetaCap

AbCellera Biologics (ABCL) vs Parabilis Medicines (PBLS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Parabilis Medicines is the larger company by market cap ($3.44 billion vs $3.16 billion), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ABCL+90.37%PBLS-13.16%
+202%+82%-39%
Jun 10, 20261 yearNov 20, 2026
ABCL+84.92%PBLS+0.66%
+171%+73%-25%
Jun 8, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ABCL versus PBLS key metrics
MetricABCLPBLS
Share price$9.69$27.44
Market cap$3.16B$3.44B
1-day change-7.45%-0.67%
YTD return+183.33%—
1-year return+176.07%—
5-year return-30.74%—
EPS (TTM)$-0.48$-3.62
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$75.13M—
Revenue growth (YoY)+160.56%—
Net income (latest FY)$-146.41M—
Operating margin-288.98%—
Net margin-194.88%—
52-week high$15.02$42.49
52-week low$2.75$22.66
Distance from 52-week high-35.46%-35.42%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+92.67%+49.42%
Average volume4.34M975.55K
Shares outstanding326.62M123.68M
Employees562145
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About AbCellera Biologics

ABCL stock →

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.

Health Care · Biotechnology: Pharmaceutical Preparations · 562 employees

About Parabilis Medicines

PBLS stock →

Parabilis Medicines, Inc. operates as a clinical-stage biopharmaceutical company focused on developing helical peptide therapeutics for disease treatment.

Health Care · Biotechnology: Pharmaceutical Preparations · 145 employees

ABCL vs PBLS FAQ

Which is bigger, AbCellera Biologics or Parabilis Medicines?

Parabilis Medicines (PBLS) is larger, with a market capitalization of $3.44B compared with $3.16B for AbCellera Biologics (ABCL).

Are AbCellera Biologics and Parabilis Medicines in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons